Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Limited research has been conducted to explore its therapeutic potential
As of 2025, The World Health Organization has come out with global guidelines recommending the use of the drug for adults living with obesity as a tool to be used during their long-term treatment
Retrospective studies suggest a beneficial effect on CRC risk and recurrence in diabetes
Always speak with your doctor before starting or continuing treatment
Front Behav Neurosci 15:786855
Trials have shown meaningful weight loss, better sugar control, and fewer heart attacks, which is why semaglutide, liraglutide, dulaglutide, and tirzepatide have now been added to the WHO Model List of Essential Medicines
US$ 21.89
US$ 21.19
US$ 20.71
